These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15624658)

  • 21. [Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner?].
    Zidek W
    MMW Fortschr Med; 2004 Jan; 146(1-2):37-8. PubMed ID: 18437867
    [No Abstract]   [Full Text] [Related]  

  • 22. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Basic principles and possible variations in combination antihypertensive therapy].
    Scholze J
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):155-63. PubMed ID: 9244658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [When blood pressure control is a problem. Refractory hypertension is rare].
    Offers E; Kolloch R
    MMW Fortschr Med; 2002 Nov; 144(46):42-4, 46. PubMed ID: 12534081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Guidelines for therapy of hypertension. One must know them--and apply them on an individual basis].
    Schmieder R
    MMW Fortschr Med; 2000 Feb; 142(7):28-30. PubMed ID: 10832330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Initial management of hypertension in a primary care service].
    Nardo P; Bovier P; Pechère-Bertschi A
    Rev Med Suisse; 2006 Sep; 2(78):2024-6, 2029-34. PubMed ID: 17019837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study].
    Schühlen H; Abts M; Kastrati D
    Herz; 2007 Aug; 32(5):419-25. PubMed ID: 17687532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total cardiovascular risk: a new treatment concept.
    Mancia G
    J Hypertens Suppl; 2006 Apr; 24(2):S17-24. PubMed ID: 16601556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antihypertensive therapy according to the ESH/ESC guidelines].
    Waeber B; Feihl F
    Rev Med Suisse; 2007 Sep; 3(124):2003-4, 2006. PubMed ID: 17955827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V
    Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fixed-dose combinations in the first line of antihypertensive therapy].
    Urbán L; Mészáros A
    Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [IQWIG Preliminary Report: Diuretics are the best antihypertensives. How does it go on with the high blood pressure therapy? (interview)].
    Sawicki P; Anlauf M; Haller H
    MMW Fortschr Med; 2007 Mar; 149(10):6-8. PubMed ID: 17408035
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimizing hypertension management in clinical practice.
    Heagerty A
    J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-responders.
    Os I
    Wien Med Wochenschr; 1995; 145(15-16):357-60. PubMed ID: 7502515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
    Weir MR; Levy D; Crikelair N; Rocha R; Meng X; Glazer R
    Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.